Schizophrenia
RecruitingA study testing direclidine compared to placebo in adults with schizophrenia who need hospital care
- Disease:Schizophrenia
- Substances:–
Bulgaria- Participants:18–64 years · 65+ years
- Sponsor:Neurocrine Biosciences Inc.
Rare diseases
Investigational molecules
Locations
Back to Bulgaria297 clinical trials in Pleven, Bulgaria across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on viral respiratory infections, including studies of vaccines against RSV, human metapneumovirus, and influenza in older adults. Clinical trials aim to enhance protection against severe respiratory diseases.
Emphasis on vaccine efficacy and immune response in vulnerable populations.
Comprehensive studies addressing various skin conditions, with particular focus on psoriasis and hidradenitis suppurativa. Research includes both systemic and targeted therapies.
Innovative approaches in chronic skin condition management.
Advanced studies in cardiovascular disease prevention and treatment, including investigations into heart failure prevention and lipid management strategies.
Focus on preventive strategies and innovative therapeutic approaches.
Investigations into various autoimmune conditions, including multiple sclerosis and Sjögren's disease, exploring new therapeutic options and treatment approaches.
Emphasis on improving quality of life for patients with chronic conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.